Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

HAHAE
Showing 5 of 22 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in HAEMONETICS CORP MASS

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 1.2M shares of HAE (HAEMONETICS CORP MASS), worth $86.7M as of 2026-Q2. The position was decreased (-16.5% shares). HAE represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$86.7M

Current Shares

1.2M

Total Value Change

+$86.7M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-16.5%
$86.7M0.0%$75.00
0
2026-Q1
Increased
1.4M
+0.2%
$77.9M0.0%$65.63
30
2025-Q4
Increased
1.4M
+994.7%
$110.6M0.1%$80.98
48
2025-Q3
New
126,067
-
$6.1M0.0%$48.12
38
2024-Q3
Exited
0
-100.0%
$00.0%$79.80
0

Other major holders of HAE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used